(Q38551004)

4 September 2017

1 reference

title

Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications (English)

1 reference

4 September 2017

1 reference

acute coronary syndrome

1 reference

2

1 reference

4 September 2017

Fabio Angeli

1

1 reference

4 September 2017

Cristina Poltronieri

3

1 reference

4 September 2017

Ludovico Lazzari

4

1 reference

4 September 2017

Martina Sordi

5

1 reference

4 September 2017

Marta Garofoli

6

1 reference

4 September 2017

Claudia Bartolini

7

1 reference

4 September 2017

Paolo Verdecchia

8

1 reference

4 September 2017

language of work or name

1 reference

19 July 2015

1 reference

Therapeutic advances in cardiovascular disease

4 September 2017

published in

1 reference

4 September 2017

volume

9

1 reference

4 September 2017

issue

6

1 reference

4 September 2017

page(s)

412-424

1 reference

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Very early initiation of statin therapy and mortality in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Statins in acute coronary syndrome: very early initiation and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

New-onset hyperglycemia and acute coronary syndrome: a systematic overview and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Acute hyperglycaemia: a 'new' risk factor during myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Admission hyperglycemia predicts poorer short- and long-term outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Prognostic Impact of Hyperglycemia in Nondiabetic and Diabetic Patients With ST-Elevation Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Admission hyperglycemia predicts inhospital mortality and major adverse cardiac events after primary percutaneous coronary intervention in patients without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Platelet activation in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Glucose Control and Mortality in Critically Ill Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

In-hospital management of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Year in review 2009: Critical Care--metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Hyperglycaemia and its therapy during acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Effects of glucose abnormalities on in-hospital outcome after coronary intervention for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Hyperglycemia, acute insulin resistance, and renal dysfunction in the early phase of ST-elevation myocardial infarction without previously known diabetes: impact on long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

The role of insulin therapy and glucose normalisation in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Stress-induced hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Prevalence of the metabolic syndrome in acute myocardial infarction and its impact on hospital outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Hyperglycemia during acute myocardial infarction. A six-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Predictive value of admission hyperglycaemia on mortality in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Value of Glycosylated Hemoglobin Measurements After Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Assessment and treatment of hyperglycemia in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Intensive insulin therapy in critical care: a review of 12 protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753944715594528

21 January 2018

Identifiers

DOI

10.1177/1753944715594528

1 reference

4 September 2017

1 reference